Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia
Sponsor: Second Affiliated Hospital of Nanchang University
Summary
To investigate whether probiotic MR-61 can assist in slowing down the progression rate of myopia (a prospective randomized controlled study).
Official title: Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Key Details
Gender
All
Age Range
3 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
164
Start Date
2025-10-01
Completion Date
2027-07-01
Last Updated
2025-12-23
Healthy Volunteers
No
Conditions
Interventions
Investigational Bifidobacterium Preparation MR-61
Oral administration of the investigational probiotic powder MR-61. The primary component is Bifidobacterium. Dosage: one sachet, 2-3 times daily, for 3 months.
Placebo for MR-61
Oral administration of a matched placebo powder. Dosage: one sachet, 2-3 times daily, for 3 months.
Locations (1)
Yifeng Yu
Nanchang, Jiangxi, China